LINC01765

Across TCGA pan-cancer cohorts, LINC01765 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01765 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC01765 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01765 expression acts as an unfavorable survival marker, although some lineages such as BRCA and PAAD show a favorable association.

BRCA, LGG, and PAAD are the cancer types where LINC01765 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Quartile	All	0.947	0.882	<.001	77	view →
LGG	OS	Median	All	0.701	0.881	<.001	52	view →
PAAD	OS	Tertile	All	0.593	0.222	.001	34	view →
HNSC	DFS	Median	III,IV	0.732	0.624	.014	32	view →
CESC	OS	Median	All	0.656	0.517	.012	30	view →
LUSC	OS	Median	III,IV	0.685	0.440	.005	29	view →
MESO	OS	Tertile	II,III,IV	0.333	0.804	.002	29	view →
READ	OS	Quartile	II,III,IV	0.802	0.550	.007	25	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
ESCA	OS	Median	III,IV	0.536	0.314	.007	16	view →
LAML	DFS	Quartile	All	0.269	0.657	.010	16	view →
GBM	OS	Quartile	All	0.280	0.500	.009	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC01765–BRCA (DFS)

Open the BRCA breakdown →